Pierre Ecclestone
Corporate Officer/Principal bij VALEO PHARMA INC.
Vermogen: - $ op 30-04-2024
Profiel
Pierre Ecclestone is currently the Vice President of Business Development at Valeo Pharma, Inc. since 2023.
Prior to this, he held the same position at Aralez Pharmaceuticals Canada, Inc. from 2021 to 2023.
Before that, he worked as a Principal at Pce Pharma Consulting, Inc. from 2017 to 2021.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
-.--% | 13-09-2023 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Pierre Ecclestone
| Bedrijven | Functie | Begin |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 01-08-2023 |
Eerdere bekende functies van Pierre Ecclestone
| Bedrijven | Functie | Einde |
|---|---|---|
| TRIBUTE PHARMACEUTICALS CANADA INC | Corporate Officer/Principal | 01-04-2023 |
| Pce Pharma Consulting, Inc. | Corporate Officer/Principal | 01-01-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VALEO PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Aralez Pharmaceuticals Canada, Inc.
 Aralez Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Canada, Inc. operates as a pharmaceutical company which focuses on the acquisition, licensing, development, and promotion of healthcare products. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The company was founded by Peter Roy Riehl and Robert Paul Harris on November 14, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
| Pce Pharma Consulting, Inc. |
